↓ Skip to main content

Dove Medical Press

Ovarian cancer: emerging molecular-targeted therapies

Overview of attention for article published in Biologics: Targets & Therapy, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Readers on

mendeley
29 Mendeley
citeulike
2 CiteULike
Title
Ovarian cancer: emerging molecular-targeted therapies
Published in
Biologics: Targets & Therapy, June 2012
DOI 10.2147/btt.s24155
Pubmed ID
Authors

Carole Sourbier

Abstract

With about 22,000 new cases estimated in 2012 in the US and 15,500 related deaths, ovarian cancer is a heterogeneous and aggressive disease. Even though most of patients are sensitive to chemotherapy treatment following surgery, recurring disease is almost always lethal, and only about 30% of the women affected will be cured. Thanks to a better understanding of the molecular mechanisms underlying ovarian cancer malignancy, new therapeutic options with molecular-targeted agents have become available. This review discusses the rationale behind molecular-targeted therapies and examines how newly identified molecular targets may enhance personalized therapies for ovarian cancer patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Pakistan 1 3%
Unknown 27 93%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 21%
Student > Ph. D. Student 6 21%
Researcher 6 21%
Student > Postgraduate 4 14%
Student > Master 3 10%
Other 3 10%
Unknown 1 3%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 45%
Medicine and Dentistry 8 28%
Biochemistry, Genetics and Molecular Biology 3 10%
Computer Science 1 3%
Physics and Astronomy 1 3%
Other 1 3%
Unknown 2 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2013.
All research outputs
#16,048,009
of 25,374,647 outputs
Outputs from Biologics: Targets & Therapy
#176
of 284 outputs
Outputs of similar age
#108,770
of 179,216 outputs
Outputs of similar age from Biologics: Targets & Therapy
#8
of 9 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,216 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.